Clinicians Hi-Dose Vit C is a potent buffered formulation containing 2 forms of Vitamin C that may effectively support the immune system in times of stress. Clinicians Hi-Dose Vit C is a potent buffered formulation containing 2 forms of Vitamin C that may effectively support the immune system in times of stress. (based on 1 review) Hi-Dose Vit C Benefits Clinicians Hi-Dose Vit C has been designed to support the body’s defenses against winter ills and chills A specialised research-based buffered formulation containing 2 forms of vitamin C, (sodium ascorbate and ascorbic acid) that may support immune function during times of stress Studies indicate that frequent high dosing with vitamin C can significantly impact the recovery period following immune stress Vitamin C may be depleted from the body during immune, physical and emotional stress, so more needs to be consumed at these times Vitamin C is also required for hormone and neurotransmitter production
Vitamin C is an antioxidant vitamin that helps to protect our cells from free radical damage Hi-Dose Vit C Features Provides a high potency buffered vitamin C dosing to rapidly restore vitamin c levels when depletion occurs due to immune stress Contains sodium ascorbate a buffered form of Vitamin C which is most well tolerated and very well absorbed. The powder offers cost effective flexible dosing to meet individual needs Contains no artificial colours or flavours It can be used alongside conventional medicine Can be taken daily for general health or high dose in times of immune stress Each level 5ml teaspoonful contains: Vitamin C (ascorbic acid) Vitamin C (from sodium ascorbate) Also contains: natural flavourings and stevia. No added: gluten, dairy, yeast, sugar, artificial colours, sweeteners, flavours or preservatives. 1 level teaspoonful in water or juice 1-2 times daily. Enhanced Dosage (for short term adult use only):
Day 1-3: 1 level teaspoonful in water or juice every 2 to 3 hours during waking hours *Monitor dosage in accordance with bowel tolerance. Day 4-7: 2 level teaspoonful twice or three times daily. After Day 7: Return to recommended adult dosage or as directed by your health professional. Do not take high doses of vitamin C if you have a gastric ulcer or ulcerative colitis. Gastric ulcer or Ulcerative colitis: vitamin C is generally well-tolerated, however people with gastric sensitivities are advised to take this product with food or to lower the dose if bowel discomfort occurs. High dosing of vitamin C may lead to bowel discomfort in some individuals. Diarrhoea, flatulence and bowel distension may occur as a result of high dosing. Reduce the dose if these symptoms are of concern. If you are on any other medication, please consult with your health professional before taking this product. If symptoms persist or you have any side affects please contact your health professional.
Suitable to take during these times. High dosing of vitamin C to bowel tolerance should be done under supervision of a health professional during these times. Studies indicate that frequent high dosing with vitamin C can significantly impact the recovery time when the body's defenses are under attack. This appears to be true for both oral and intravenous vitamin C administration. In addition to supporting recovery, these high-dosing regimes may also support the body's recovery times. In order to get the full benefit of this regime, you should dose to bowel tolerance. Bowel tolerance is reached when the following symptoms occur; bowel discomfort, distention, diarrhoea and flatulence. Individual requirements for vitamin C may vary depending on severity of illness and levels of stress and higher dosing may be required during these times. Once bowel tolerance is achieved, you should continue on the maintenance dose recommended for this product, You may also benefit from taking the following Clinicians products alongside Hi-Dose Vit C : Stress & Energy Support (to address fatigue & lethargy), VirActive Seasonal, Vitamin B12 Oral Drops and Del- Immune V® (for additional immune support),LipGuard (for lip health in times if immune stress), MultiVitamin and Mineral Boost for added mineral and nutrient support.
hi dose vitamin c by charmaine robinson from Raetihi I love this product...I take it regularly........ | Write your own review below Your review title (required)... Yes, include me in your regular newsletter Write your review here (required)... Please note: we reserve the right to use all product reviews we receive in our marketing and promotional material, both on and offline, identifying reviewers by first name only. If you so not want us to use your review, please let us know.A previous study in by Choi et al in the USA showed that people with a higher vitamin C intake have a lower risk of gout. There are also studies in healthy volunteers that suggest that vitamin C supplements reduce blood uric acid levels. It is thought that vitamin C increases the excretion of uric acid in the urine. The exact mechanism is not known, however, it is thought to be something to do with the way the kidneys excrete uric acid. There is some evidence that vitamin C might also reduce production of uric acid as well but the major mechanism is thought to be through increasing excretion through the kidneys.
We recruited gout patients who had blood uric acid levels greater than the treatment target level of 0.36 mmol/L (6 mg/100 mL). Of the 40 participants with gout, 20 patients taking allopurinol were given an additional 500 mg dose of vitamin C daily or had the dose of allopurinol increased, while another 20 patients were either started on allopurinol or vitamin C (500 mg/day). We analyzed blood levels of vitamin C (ascorbate), creatinine and uric acid at baseline and week eight. Our study showed that a modest vitamin C dose (500mg/d) for eight weeks did not lower urate levels to a clinically significant degree in gout patients, but did increase blood levels of ascorbate (vitamin C). Patients were given vitamin C pills.The dose of vitamin C we gave was higher than the daily recommended intake and the blood levels of ascorbate (vitamin C) increased suggesting that patients were receiving adequate amounts.The degree of change in uric acid levels is similar to that seen in other studies.
The amount of change is unlikely to have any significant clinical benefit for patients with gout. Higher doses of vitamin C could be studied, however the risks of higher doses needs to be considered. The dose we gave is already above the recommended daily dose and the blood levels reached a point where increasing them further was unlikely to have any extra effect. Cherries have been reported to lower uric acid levels in women. They have also been reported to reduce the number of gout attacks. The mechanism by which cherries exert these effects is not entirely clear. It has been suggested that cherries increase uric acid excretion via the kidneys and may lower urate production. There are also other anti-inflammatory chemicals in cherries that may have an effect. The amount of vitamin C in cherries is probably not high enough to have any effect. The two most common reasons patients don’t reach appropriate urate levels are not taking the medicines that lower uric acid levels regularly and that the dose of the medicine is too low.
The research was funded by the Health Research Council of NZ. We have plans to look at the effects of omega three fats in acute gout. There are two things you need to do when you are treating gout. Firstly, you need to treat the acute attacks as they come, secondly, in the long term you need to lower the uric acid to prevent the attacks from coming. Omega three fats work like a natural anti-inflammatory. The study, which is being led by one of my colleagues in Wellington, will look at whether we could treat those acute attacks of gout by omega three fats rather than using anti-inflammatory drugs. Anti-inflammatory drugs can have quite a lot of side effects. Patients can look on the clinical trial registry web sites for studies on gout medicines. Professor Lisa Stamp is a Rheumatologist at the University of Otago, Christchurch and Christchurch Hospital. She is director of the Canterbury Rheumatology Immunology Research Group and the University of Otago Arthritis Research Theme.